Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19606 AL 19620

Korean Addenbrooke's Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer's disease and subcortical ischemic vascular dementia

Kwak YT, Yang Y, Kim GW.

Geriatr Gerontol Int. 2010 Oct;10(4):295-301. doi: 10.1111/j.1447-0594.2010.00624.x. Epub 2010 May 17.

Some observations about two versions of mental status examinations: implications for screening dementia patients in nursing homes

Zimmer AT, Chovan MJ, Chovan WL.

Percept Mot Skills. 2010 Apr;110(2):348-52. doi: 10.2466/PMS.110.2.348-352.

Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration

Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J.

Dement Geriatr Cogn Disord. 2010;29(5):448-56. doi: 10.1159/000312685. Epub 2010 May 26.

A new story about an old guy: is Alzheimer's disease infectious?

Reis HJ, Mukhamedyarov MA, Rizvanov AA, Palotás A.

Neurodegener Dis. 2010;7(4):272-8. doi: 10.1159/000309659. Epub 2010 May 27.

The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease

Pan XL, Ren RJ, Wang G, Tang HD, Chen SD.

Neurosci Bull. 2010 Jun;26(3):241-6. doi: 10.1007/s12264-010-1109-7.

DNA damage and impairment of DNA repair in Alzheimer's disease

Obulesu M, Rao DM.

Int J Neurosci. 2010 Jun;120(6):397-403. doi: 10.3109/00207450903411133.

NIA-funded Alzheimer centers are more efficient than commercial clinical recruitment sites for conducting secondary prevention trials of dementia

Edland SD, Emond JA, Aisen PS, Petersen RC.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):159-64. doi: 10.1097/WAD.0b013e3181c9983f.

A single ascending dose study of bapineuzumab in patients with Alzheimer disease

Black RS, Sperling RA, Safirstein B, Motter RN, Pallay A, Nichols A, Grundman M.

Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):198-203. doi: 10.1097/WAD.0b013e3181c53b00.

Botulinum toxin as a solution in voluntary hip dislocation after modular unipolar hemiarthroplasty

Eren A, Ozkan K, Unay K, Sahin A, Poyanli O.

Orthopedics. 2010 May 12;33(5). doi: 10.3928/01477447-20100329-25.

Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study

Marner L, Frokjaer VG, Kalbitzer J, Lehel S, Madsen K, Baaré WF, Knudsen GM, Hasselbalch SG.

Neurobiol Aging. 2012 Mar;33(3):479-87. doi: 10.1016/j.neurobiolaging.2010.03.023. Epub 2010 May 26.

Macrophages in Alzheimer's disease: the blood-borne identity

Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T.

J Neural Transm (Vienna). 2010 Aug;117(8):961-70. doi: 10.1007/s00702-010-0422-7. Epub 2010 Jun 2.

APP transgenic mouse models and their use in drug discovery to evaluate amyloid- lowering therapeutics

Hussain I.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):395-402. doi: 10.2174/187152710791556087.

The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease

Wilcock DM.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):386-94. doi: 10.2174/187152710791556168.

Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study)

Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Giraudeau B, Cantet C, Coley N, Vellas B; PLASA Group.

BMJ. 2010 Jun 3;340:c2466. doi: 10.1136/bmj.c2466.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias